Related Experiment Video
Updated: Jan 30, 2026

Clonal Genetic Tracing using the Confetti Mouse to Study Mineralized Tissues
Published on: October 23, 2019
Genetic predisposition to MDS: clinical features and clonal evolution
Alyssa L Kennedy1, Akiko Shimamura1
1Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
Abstract:
Myelodysplastic syndrome (MDS) typically presents in older adults with the acquisition of age-related somatic mutations, whereas MDS presenting in children and younger adults is more frequently associated with germline genetic predisposition. Germline predisposition is increasingly recognized in MDS presenting at older ages as well. Although each individual genetic disorder is rare, as a group, the genetic MDS disorders account for a significant subset of MDS in children and young adults. Because many patients lack overt syndromic features, genetic testing plays an important role in the diagnostic evaluation. This review provides an overview of syndromes associated with genetic predisposition to MDS, discusses implications for clinical evaluation and management, and explores scientific insights gleaned from the study of MDS predisposition syndromes. The effects of germline genetic context on the selective pressures driving somatic clonal evolution are explored. Elucidation of the molecular and genetic pathways driving clonal evolution may inform surveillance and risk stratification, and may lead to the development of novel therapeutic strategies.
Insights
Genetic predisposition is key in myelodysplastic syndromes (MDS), especially in younger individuals. Understanding these genetic factors aids diagnosis, management, and developing new therapies for MDS.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are often linked to somatic mutations in older adults.
- In contrast, pediatric and young adult MDS frequently involves germline genetic predisposition.
- Germline predisposition is also increasingly identified in older MDS patients.
Purpose of the Study:
- To review syndromes associated with genetic predisposition to MDS.
- To discuss clinical evaluation, management, and scientific insights from MDS predisposition syndromes.
- To explore the impact of germline genetics on somatic clonal evolution in MDS.
Main Methods:
- Literature review of genetic MDS predisposition syndromes.
- Analysis of clinical implications for evaluation and management.
- Exploration of molecular and genetic pathways in clonal evolution.
Main Results:
- Genetic MDS disorders represent a significant proportion of MDS in children and young adults.
- Genetic testing is crucial for diagnosis, as overt syndromic features are often absent.
- Germline genetic context influences selective pressures driving somatic clonal evolution.
Conclusions:
- Elucidating genetic MDS pathways can improve surveillance and risk stratification.
- Understanding germline predisposition may lead to novel therapeutic strategies for MDS.
- Genetic testing is vital for diagnosing MDS, particularly in younger populations.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Convergent Evolution
The Evidence for Evolution
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests

